A targeted cancer drug niraparib, used in combination with hormone therapy, was found to reduce the risk of prostate tumor ...

The FDA has approved the combination of lurbinectedin (Zepzelca) and atezolizumab (Tecentriq) as a first-line maintenance treatment for patients with extensive-stage small cell lung cancer (ES-SCLC) ...

The FDA has approved the combination of lurbinectedin (Zepzelca) and the immunotherapy atezolizumab (Tecentriq) for first-line maintenance treatment in patients with extensive-stage small cell lung ...

Imagine knowing in your 20s or 30s that you carry a gene that will cause your mind and body to slowly unravel.

From cancer biology to proactive health management, customized care is changing patient outcomes, but what are the costs and ...

A novel targeted radiation approach for a rare form of malignant tumor—the solitary fibrous tumor (SFT)—has shown significant success, achieving a near-complete response in three patients. The therapy ...

As September concludes, the landscape of GU oncology continues to evolve, with important developments in prostate, bladder, ...

A recent study revealed that targeted radiation therapy may offer a protective alternative to treating an arrhythmia, ...

Targeted radiation therapy might be a safer way to treat a potentially dangerous heart rate problem called ventricular ...

An international team of clinical collaborators, led by physician scientists from Dana-Farber Cancer Institute, performed a first-ever clinical test of the targeted therapy avapritinib in pediatric ...